New benchmarks for addressing product toxicity, even in areas of scientific uncertainty

Get RSS feed of these results

All components of this story

Article
10 February 2005

Benchmarking Corporate Governance on Product Toxicity and Safer Alternatives

Author: William Baue, SocialFunds.com

The benchmark, released by the Rose Foundation today, addresses the scientific uncertainty of product toxicity through risk assessment and opportunity identification instead of inaction. [refers to General Electric, Avon, Baxter, Cardinal, JC Penney, Kimberly-Clark, SC Johnson]

Read the full post here

Article
1 January 2005

[PDF] Protecting Public Health, Increasing Profits And Promoting Innovation By Benchmarking Corporate Governance of Chemicals in Products

Author: Richard A. Liroff, World Wildlife Fund

[Case studies on Samsung, Fujitsu, Sony, SC Johnson, Nike, Marks & Spencer, Boots, Gerber Products (part of Novartis), Chiquita. Also refers to Apple, Avon, Baxter, Compaq (part of Hewlett-Packard [HP]), Hewlett-Packard (HP), IBM, Abbott Laboratories, Bristol-Myers Squibb, Tyco, Cardinal, HCA, Dow Chemical, General Electric, Georgia Pacific, Mead, Weyerhaeuser, Willamette Industries, Kimberly-Clark, Eastman Kodak, ChevronTexaco, Supervalu, JC Penney, Swiss Re, Ikea, B&Q (part of Kingfisher), Body Shop, Great Lakes Chemical, 3M, DuPont]

Read the full post here